TY - JOUR
T1 - Clinical assessment and management of cancer-related fatigue
AU - Narayanan, Santhosshi
AU - Escalante, Carmelita P.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017/5
Y1 - 2017/5
N2 - Objective: To review the evidence on interventions for managing cancer-related fatigue (CRF) and provide evidence-based guidance on approaches to its management. Methods: Nonsystematic review of the literature. Results: Several theories have been proposed to explain the biology of CRF, but there is no single clear mechanism that can be targeted for therapy. The approach to patients begins with screening for fatigue and assessing its intensity, followed by a thorough history and examination to determine whether any reversible medical conditions are contributing to fatigue. Management of underlying medical comorbidities may help some patients. For patients whose fatigue persists, pharmacologic and nonpharmacologic treatment options are available. Pharmacologic options include psychostimulants, such as methylphenidate and modafinil, and corticosteroids. Nonpharmacologic approaches include exercise, cognitive behavior therapy, yoga, acupuncture, and tai chi. Conclusion: We recommend an individualized approach, often with a combination of the available options. Patients need to be evaluated periodically to assess their fatigue, and since cancer-related fatigue affects survivors, long-Term follow-up is needed.
AB - Objective: To review the evidence on interventions for managing cancer-related fatigue (CRF) and provide evidence-based guidance on approaches to its management. Methods: Nonsystematic review of the literature. Results: Several theories have been proposed to explain the biology of CRF, but there is no single clear mechanism that can be targeted for therapy. The approach to patients begins with screening for fatigue and assessing its intensity, followed by a thorough history and examination to determine whether any reversible medical conditions are contributing to fatigue. Management of underlying medical comorbidities may help some patients. For patients whose fatigue persists, pharmacologic and nonpharmacologic treatment options are available. Pharmacologic options include psychostimulants, such as methylphenidate and modafinil, and corticosteroids. Nonpharmacologic approaches include exercise, cognitive behavior therapy, yoga, acupuncture, and tai chi. Conclusion: We recommend an individualized approach, often with a combination of the available options. Patients need to be evaluated periodically to assess their fatigue, and since cancer-related fatigue affects survivors, long-Term follow-up is needed.
KW - Cancer
KW - Fatigue
KW - Nonpharmacologic
KW - Pro-inflammatory cytokines
KW - Psychostimulants.
UR - http://www.scopus.com/inward/record.url?scp=85019681889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019681889&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:85019681889
SN - 1079-6533
VL - 24
SP - 217
EP - 228
JO - Journal of Clinical Outcomes Management
JF - Journal of Clinical Outcomes Management
IS - 5
ER -